The SHAPE recognition follows a streak of industry wins for the Nashville-based company, including a distinction from NewBeauty and a spot in the 2026 Parade Better Than Ever Beauty Awards. These honors highlight the brand's attempts to bridge the gap between high-potency retinoids and daily skin tolerability. According to CEO Keith O'Briant, the formulation was engineered specifically to bypass the irritation often associated with traditional retinoid treatments, utilizing the company's proprietary RetaXome and Supercharged HA delivery systems.
Originally established as a regenerative medicine firm focused on wound care and oncology-related drug delivery, HYDRINITY has transitioned into the aesthetic space by applying injectable-grade standards to topical formulations. Since its 2022 market entry, the company has expanded its footprint to over 6,000 professional practices globally. The RetaXome Daily Retinal Hydrator, currently available through authorized clinical partners and the company’s website, continues to serve as the flagship example of their efforts to combine clinical efficacy with daily skincare routines.
Comments (0)
No comments yet. Be the first!